Mylan Investor Relations

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 2,700 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 40,000-strong workforce is dedicated to creating better health for a better world, one person at a time.


Mylan (MYL) NASDAQ | Feb 17, 2017, 4:00 ET

+ 0.05
Day High: 42.33
Day Low: 41.78
Volume: 6,616,387
52-Week High: 50.40
52-Week Low: 33.60


Mylan Investor Day
Location: New York City

March 01, 2017

35th Annual J.P. Morgan Healthcare Conference
Location: San Francisco

January 11, 2017


In order to set new standards in healthcare, we have leaders dedicated to helping people gain access to affordable medicine on a global scale. Learn about the passionate people who carry out Mylan’s day-to-day business and bring quality to our facilities.

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.